Enwei Pharmaceutical Co., Ltd. (SZSE: 301331)
Health Care · Pharmaceuticals · CN
CN¥22.12
+1.28% today · -28.5% 1Y
Enwei Pharmaceutical Co., Ltd. (SZSE: 301331) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $336.44M.
Over the last twelve months the share price has lost 28.5%, trading between 18.87 and 33.50.
Tweenvest scores Enwei Pharmaceutical Co., Ltd. across four factors: quality 79/100, value 45/100, growth 66/100, dividend 51/100. Its strongest factor is quality.
301331 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $336.44M
- Revenue (TTM)
- $121.62M
- P/E
- 78.11
- EPS
- 0.28
- Dividend yield
- 4.66%
- Beta (5Y)
- 0.57
- 52-week high
- CN¥33.50
- 52-week low
- CN¥18.87
- Avg volume (3M)
- —
- Shares outstanding
- 101.88M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Swedencare AB (publ)OM: SECARE | $342.89M | Skr22.70 | +5.83% |
| Boiron SAENXTPA: BOI | $342.15M | €17.25 | -1.99% |
| Hanshang Group Co., Ltd.SHSE: 600774 | $341.73M | CN¥7.92 | -0.63% |
| Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.SHSE: 603168 | $337.37M | CN¥6.04 | +3.25% |
| Ildong Pharmaceutical Co., Ltd.KOSE: A249420 | $328.58M | ₩14,020.00 | -3.38% |
| Guhan Pharmaceutical Group Co., Ltd.SZSE: 000590 | $328.20M | CN¥9.18 | +0.88% |
| Abbott Laboratories (Pakistan) LimitedKASE: ABOT | $327.56M | PKRs926.50 | +0.19% |
| Ind-Swift Laboratories LimitedNSEI: INDSWFTLAB | $324.28M | Rs360.90 | -8.67% |
Figures last refreshed Oct 11, 2026.